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Abstract Arthroscopic knee joint lavage is used when
conservative treatment of knee osteoarthritis is unsat-
isfactory and a joint prosthesis is not yet indicated. The
potentially negative effect of irrigation fluids on carti-
lage metabolism and structure has led to the develop-
ment of a temporary synovial fluid substitute containing
hyaluronic acid. The short and long-term effects of this
synovial fluid substitute were investigated in a total of
80 patients with persistent knee pain. Forty patients
underwent arthroscopic knee joint lavage, in some
cases combined with careful cartilage debridement
(group A) while a further 40 patients underwent the
same procedure which, after final joint lavage, was
immediately followed by a single instillation of 10 ml of
the synovial fluid substitute (0.5% sodium hyaluronate)
into the joint (A + HA group). After the procedure,
pain on walking and restricted ability to walk 100 m
were markedly reduced to a comparable extent in both
groups. Three months later, the effect of the treatment
assessed using various parameters (CGI, restricted
ability to walk 100 m, pain on walking, night pain) had
decreased in group A, while it remained stable or even
improved slightly in the A + HA group. The Mann–
Whitney statistics revealed a descriptive superiority for
the A + HA group at this time point. One year after
treatment the superiority of the A + HA group was
confirmed using the same assessment parameters. No
side effects or adverse events were observed for either
treatment procedure. This study shows that arthro-
scopic knee joint lavage leads to a lasting improvement
in pain and functional impairment. The post-arthro-
scopic instillation of a HA-based synovial fluid
substitute into the joint is a suitable way of achieving
long-term stabilisation of the treatment outcome. This
was supported by findings of a survey of 66 patients at
2 years after treatment in this study. Level I prospec-
tive, randomised controlled double-blind study.
Keywords Intra-articular  Hyaluronic acid 
Knee osteoarthritis  Arthroscopic knee joint lavage 
Debridement
Introduction
Pain and impaired knee joint function reduces the ra-
dius of action and quality of life of the patients con-
cerned. Osteoarthritic changes play a causative role
particularly in the elderly [1]. Where conservative
measures such as physiotherapy, oral analgesics, non-
steroidal anti-inflammatory drugs or intra-articular
injections of, for example, corticosteroids are no longer
sufficiently effective, arthroscopic knee joint lavage,
possibly supplemented by smoothing of the cartilage,
may be considered as the next step. The purpose of this
minimal procedure is to remove the products of carti-
lage wear, inflammatory cells and molecules from the
joint and therefore counter the onset of painful infla-
mmatory phases (‘‘activated osteoarthritis’’).
Hyaluronic acid (HA) is a long-chain biopolymer
made up of continuously repeated molecular sequences
of N-acetyl-glucosamine and glucuronic acid. In joint
cartilage, HA functions as the backbone for proteo-




82418 Murnau am Staffelsee, Germany
e-mail: hempfling@bgu-murnau.de
123
Knee Surg Sports Traumatol Arthrosc (2007) 15:537–546
DOI 10.1007/s00167-006-0260-1
cellular matrix in which the chondrocytes are embed-
ded. The surfaces of the cartilage and synovial mem-
brane are coated with HA. HA also plays a particular
role in synovial fluid, giving it its shock absorbing and
viscoelastic properties. In addition, the tightly inter-
woven macromolecules of HA in the joint space form
a molecular sieve which prevents the free passage of
inflammatory cells and molecules, while allowing the
flow of catabolic compounds from the synovial mem-
brane to the non-vascularised joint cartilage. In
osteoarthritis, exogenous HA injected into the joint
space has been shown to improve the qualitative and
quantitative properties of endogenous HA and there-
fore improve joint lubrication (concept of viscosup-
plementation) [1].
During arthroscopy, the irrigation fluid not only
removes harmful detritus but also the synovial fluid
and the HA layer covering the joint tissues including
the cartilage. Although most of the fluid is removed
from the joint after the procedure, some remains and
experimental studies have shown that irrigation fluids
used in arthroscopy can have a negative effect on the
metabolism and structure of the joint cartilage [2, 18,
20]. This led to the development of the concept of
replacing the lost synovial fluid with an HA-containing
synovial fluid substitute immediately after arthroscopy.
The aim of this study was therefore to investigate the
short- and long-term effects and safety of such an HA-
containing synovial fluid substitute when used after
arthroscopic joint lavage.
Patients and methods
A total of 80 patients suffering from severe knee joint
pain for at least 6 months (pain VAS > 50 mm) and in
whom arthroscopic joint lavage (and possibly intra-
operative cartilage smoothing) was indicated were
recruited into a single-centre, randomised, controlled,
double blind study. The study protocol was approved
by an Institutional Review Board (IRB) and the in-
formed consent was obtained from each patient. The
study was conducted in accordance with the study
protocol and good clinical practice (GCP) [11]. Pa-
tients with joint disease that could interfere with the
outcome of treatment, those with severe systemic dis-
ease, those in whom the investigational product or
arthroscopic treatment were contraindicated and those
who had received intra-articular treatment during the
6 months preceding the study were excluded from the
study. The use of other therapeutic agents was pro-
hibited throughout the study, except for pain medica-
tion (acetaminophen up to 2 g per day). During the
first 2 weeks following the procedure an accurate re-
cord was to be kept of any acetaminophen taken.
All 80 patients were treated with the same arthro-
scopic technique, as follows. Patients were positioned
on their backs with the knee to be treated supported by
a knee wedge in approximately 30 flexion. A tourni-
quet cuff was fitted as a precautionary measure. The
procedure was carried out under general anaesthesia,
nerve block and, in a few cases, local anaesthesia. Once
anaesthesia was established, the arthroscope (5.5 mm
external diameter) was introduced through a 3–4 mm
stab incision using the anterolateral or high anterolat-
eral approach.
First a thorough examination of the entire joint was
carried out with precise location of the chondral lesion
and its grading according to the Outerbridge classifi-
cation [17] The chondral lesions were then treated by
lavage or debridement. Lavage involved irrigating the
knee joint with at least 3,000 ml Ringer’s solution
while debridement involved the smoothing of the car-
tilage and/or meniscus. All smoothing procedures were
performed with restraint and, where possible, only
necrotic or floating chondral tissue was removed from
the cartilage, creating mechanically favourable transi-
tions with the adjacent chondral surfaces. The menis-
cus was resected only where there were degenerative
tears to the posterior horn and concomitant degener-
ative chondral lesions. In this case the torn section
of meniscus was resected and the margin carefully
smoothened. For debridement, rongeurs and chisels
were used for the removal of exophytes. Occasionally
shaver systems were also used, always combined with
subsequent lavage. The irrigation pressure was suffi-
ciently high to produce a jet of fluid containing detritus
and tissue fragments through the arthroscope shaft.
Suction drains were not required in any patient and
there was no postoperative resting, so that the earliest
possible mobilisation with full weight bearing was
achieved. No specific treatment was prescribed during
the complete follow-up period.
Forty patients received only arthroscopic treatment
(group A) while a further 40 patients received an
instillation into the joint of 10 ml of a 0.5% HA solu-
tion (Viscoseal, 10 ml/50 mg ampoules, TRB Che-
medica AG, D-85540 Haar) after completion of the
procedure and removal of the irrigation fluid (group
A + HA). The concentration of HA used in Viscoseal
is the same as that of healthy synovial fluid, with a
mean molecular weight of 1.6 million Daltons. Visco-
seal is presented in flexible ampoules which are
sealed into a sterile sachet and then autoclaved. The
double blind nature of the study was ensured as fol-
lows: the patient was either under general anaesthesia
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throughout the treatment or, where epidural or local
anaesthesia was used, had no view of the operating
area. The doctor making the assessments was given no
information on the type of treatment each patient re-
ceived. The status of the joint prior to treatment was
assessed during the operation using the Outerbridge
classification of chondral lesions [17]. The medial and
lateral femoral condyle, the medial and lateral tibial
plateau and medial and lateral patella plus trochlea
were assessed using a four-point score (1 = local soft-
ening and swelling of the cartilage, 2 = fissure forma-
tion and fragmentation up to a diameter of 1.3 cm,
3 = fissure formation and fragmentation with a dia-
meter of more than 1.3 cm, 4 = ulcers and erosions
reaching the subchondral bone).
The efficacy of the treatment was assessed using
validated scales and patient questionnaires. The pri-
mary efficacy parameter was pain monitored using the
Huskisson 100 mm visual analogue scale (VAS) [10]
on which 0 indicates ‘‘no pain’’ while 100 indicates
‘‘unbearable pain’’. Pain assessments were performed
both, by the patients through daily entries in a pain
diary for 2 weeks postoperatively and by the Investi-
gator at 6 h and 2 weeks after the operation. The pa-
tient’s overall impression of the treatment outcome
(clinical global impression, CGI) was assessed using a
five-point ordinal scale (1 = very good/symptom-free,
2 = good/clearly improved, 3 = satisfactory/slightly im-
proved, 4 = unchanged, 5 = worse). Restricted ability
to walk 100 m were recorded using a five-point ordinal
scale (0 = no difficulties, 1 = slight, 2 = considerable,
3 = major, 4 = extreme). The presence/absence of pain
on walking 100 m (pain on exercise) and in the night
(pain at rest) were recorded (Yes/No). Assessments
were made at baseline (V0—i.e. 1–2 days before the
operation), at time of operation (V1—i.e intraopera-
tive findings), and then at 6 h (V2), 2 weeks (V3),
3 months (V4) and 1 year (V5) post-surgery (Tables 1).
This timescale allowed the assessment of the short-
(V2, V3 and V4) and long-term (V5) effects of treat-
ment. To assess the longer-term outcome, patients
completed a further questionnaire at 2 years post-
surgery. This recorded CGI, pain on walking 100 m,
night pain and restricted ability to walk 100 m.
Statistical evaluation
Since joint irrigation is described in the literature as an
effective treatment for knee problems, we wished to
determine whether non-inferiority could be demon-
strated for the investigational product, Viscoseal.
Data for all patients were used in evaluating the
safety aspect of the investigational product. Thirty-
eight patients from group A and 36 patients from the
A + HA group were included in the ITT (intention-to-
treat) data set for primary analysis. Statistical evalua-
tion initially examined whether the new treatment
method A + HA was not inferior to the established
procedure A with regard to efficacy. If significance was
achieved, a test for superiority was performed at the
same alpha level (2.5%). The hypotheses were tested
using the measure of relevance. In the case of the
primary efficacy parameter (pain VAS), standardised
difference (= diff/s) was used, while the secondary
parameters were analysed using the Mann–Whitney
reference value. The limit for non-inferiority was the
mean inferiority according to Cohen and the limit for
superiority was equality according to Cohen. The
findings of the patient survey 2 years after the proce-
dure were also subjected to statistical evaluation as
described (Table 2).
Results
A total of 41 women and 39 men (mean age
60.9 ± 8.1 years; mean height 171.2 ± 8.5 cm; mean



















VAS (assessed by Investigator) X X X
VAS pain diary (patient) Daily for 2 weeks
Clinical global impression, patient (CGI) X X X X X
Restricted ability to walk 100 m X X X X X X
Pain on walking 100 m X X X X X X
Night pain X X X X X X
Safety X X X X X
Knee Surg Sports Traumatol Arthrosc (2007) 15:537–546 539
123
body weight 79.6 ± 14.7 kg) were included in the study.
The comparison of homogeneity for these and almost
all other parameters at the baseline visit (V0) showed
equality between the two groups of patients. Slight
differences between the groups were found only with
respect to restricted ability to walk 100 m (Fig. 3).
To allow better comparability with other studies,
the findings of the intra-operative assessment (V1) of
chondral lesions, according to the four-stage Outer-
bridge scheme, were transferred to the three-stage
classification of Ficat and Hungerford [6]. This was
achieved by combining Outerbridge stages II and III
into Ficat and Hungerford stage II. In this assessment
there was found to be slightly more severe damage
to the medial (group A 2.16 ± 0.52; group A + HA
2.23 ± 0.59) and patellofemoral compartments (group
A 2.02 ± 0.51; group A + HA 2.17 ± 0.55) compared
to the lateral joint compartment (group A 1.86 ± 0.61;
group A + HA 2.03 ± 0.65) and more pronounced
chondral lesions in group A + HA than in group A. No
correlation was found between the location and
severity of chondral damage and the preoperative
clinical findings or the postoperative course. No
appreciable damages of the menisci were found in the
study population. In light of the arthroscopic findings,
cartilage debridement with joint lavage was performed
in 9 patients in group A and 11 patients in group
A + HA. As the postoperative progress of patients
who also underwent debridement did not differ
appreciably from that of patients who underwent joint
lavage alone, these patients were also included for
subsequent assessments.
Changes in pain symptoms (VAS) during the
14 days post-surgery (V0, V2 and V3) were very pos-
itively assessed both by the doctor and by the patients.
Assessment by the doctor showed that the previously
severe pain decreased markedly in both groups as a
result of arthroscopic treatment of the joint. In the
group not receiving subsequent treatment with HA
(group A) the severity of the pain showed a mean
decrease from 66.1 ± 11.7 mm VAS before the proce-
dure to 20.2 ± 18.0 mm at 6 h after the procedure and
to 17.1 ± 20.1 mm at 14 days. In the A + HA group,
pain decreased in a similar way from 65.8 ± 10.4 mm
(V0) to 20.5 ± 16.4 mm (V2) and 15.8 ± 13.8 mm (V3).
Daily records made by the patients showed a decrease
in pain severity by 40.8% by Day 14 in group A and
42.7% in group A + HA. An inter-group comparison
showed no significant difference between the groups.
During the interval between V4 and V5, two
patients from group A and four from group A + HA
left the study for reasons (joint replacement, repeat
arthroscopy required) not attributable to study treat-
ment. Therefore, 1 year after the procedure, data for
74 patients (group A 38, group A + HS 36) were still
available for assessment of CGI, pain during exercise
and at rest and restricted ability to walk 100 m.
The overall impression of patients regarding the
success of the treatment (CGI) was very positive in
both groups over a period directly following the pro-
cedure but subsequently showed increasing superiority
of the A + HA group up to 1 year afterwards (Fig. 1).
Shortly after the procedure (V2) most patients re-
ported a marked improvement or were even symptom-
free (87.5% in the A group, 90.0% in the A + HA
group). This assessment remained largely unchanged
after 14 days (V3) (82.5% in the A group, 87.5% in the
A + HA group). Three months after arthroscopy (V4),
however, the treatment outcome was assessed to be
considerably more favourable in the A + HA group
(‘‘clearly improved’’ and ‘‘free from symptoms’’:
82.5% compared with 65.0% in the A group). This
trend was even more pronounced 1 year after treat-
ment (V5). Seventy-five percentage of patients from
the A + HA group had a good to very good global
impression of the treatment while this was the case in
only 50% of patients from the A group. In the statis-
tical analysis (Mann–Whitney), this trend was reflected
as follows: at 14 days (V3) and 3 months (V4) after
arthroscopy, non-inferiority was recorded for the
A + HA group, whereas 1 year after the procedure
(V5) proven superiority was observed for the A + HA
group (Fig. 2).
Before arthroscopy, 76.9% of patients from the A
group and 85.0% from the A + HA group (Fig. 4)
complained of restricted ability to walk 100 m. Com-
pared with the baseline findings, over 50% of the pa-
tients in the A group showed an improvement of one
or more score points, (e.g. from ‘‘extreme’’ to ‘‘slight’’
difficulties (V2 59.0%, V3 61.5%, V4 59.0%, V5
59.5%) concerning this parameter. However, the
number of improved patients was considerably higher
Table 2 Intra-operative assessment of chondral lesions per









Grade 1 1 6 3
Grade 2 24 16 27
Grade 3 14 4 4
A + HA group
Grade 1 3 3 2
Grade 2 22 18 23
Grade 3 14 9 8
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in the A + HA group (V2 75.0%, V3 77.5%, V4
77.5%, V5 77.8%). The number of patients with no
restricted ability to walk increased in group A from
23.1% preoperatively to 60.5% at 1 year (V5) after the
procedure. In the A + HA group a very much clearer
increase in the percentage of symptom-free patients,
from 15.0 to 88.9%, was observed. Also, at the last visit
9.1% of the patients in group A still had ‘‘major’’
problems in walking 100 m, while none of the patients
from the A + HA group reported more than ‘‘consid-
erable’’ problems (Fig. 3). Statistical analysis (Mann–
Whitney), as with the global assessment of efficacy by
patients, again showed non-inferiority at 14 days (V3)
and 3 months (V4) after the procedure and proven
superiority at 1 year (V5). These data are not pre-
sented here.
Before arthroscopy, 76.9% of the patients from
group A and 87.5% from the A + HA group com-
plained of pain on walking 100 m (Fig. 4). Immediately
after the arthroscopy, considerably fewer patients in
both groups initially suffered pain on walking (V2
group A 32.5%, A + HA group 41.0%). During the
study however, the proportion of pain-free patients
in group A increased only slightly and after 1 year
(V5) more than one-third of the patients (39.5%)
still complained of pain on walking. In contrast, the
proportion of pain-free patients in the A + HA group
increased continuously during the study such that at
1 year (V5) only 13.9% still complained of pain on
walking. Statistical analysis (Mann–Whitney) again
showed non-inferiority for the A + HA group at
14 days (V3) and 3 months (V4) and proven superi-
ority at 1 year (V5) after the procedure.
Another efficacy parameter in this study was pain at
rest (‘‘night pain’’) (Fig. 5). Before arthroscopy 48.7%
of patients in group A and 66.7% in the A + HA group
had reported this symptom. Immediately after
arthroscopy, most patients were initially pain-free (at
V2 92.5% in group A, 90.0% in the A + HA group).
However the proportion of patients with pain at rest

























































6 hours 2 weeks 3 months 1 year 2 years
A+HA group
Fig. 1 Clinical global
impression (CGI) by the
patients during the study.
(A group arthroscopy;



























6 hours 2 weeks 3 month 1 year 2 years
Superiority of A group
Superiority of A+HA group
Fig. 2 Clinical global impression by patients. The dashed line at
0.36 is the benchmark for the effect size ‘medium sized
inferiority’. At 3 months after treatment the Mann–Whitney
statistics showed a descriptive superiority in favour of the
A + HA group while at 1 year after treatment there was a
proven superiority (since Mann–Whitney value and the confi-
dence interval are above the benchmark for ‘equality’ at 0.5) in
favour of the A + HA group. The Mann–Whitney statistics for
all other efficacy parameters led to similar results. (A group
arthroscopy; A + HA group arthroscopy + hyaluronic acid)
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31.6% of these patients again reported this symptom.
In contrast, only 11.1% of the patients in the A + HA
group complained of pain at rest at this visit. Statistical
analysis by the Mann–Whitney method for the para-
meter pain at rest at 6 h (V2) after arthroscopy and
again at 14 days (V3) and 3 months (V4) showed non-
inferiority for the A + HA group. One year after the
procedure (V5) proven superiority was observed for
the A + HA group. Adverse events or effects showing
a causal relationship with the investigational product
were not recorded in any patient.
Data for 66 patients (33 in each group) were avail-
able for statistical assessment at 2 years after the pro-
cedure: eight patients had to undergo additional
treatment after visit 5 (e.g. total knee replacement,
arthroscopy or shock wave treatment) and were
therefore not included in the assessment. The mean
time to the two-year follow-up was 414.7 days (range
308–559 days) for the patients in group A and
423.5 days (range 314–560 days) for the patients in the
A + HA group.
Although differences between the groups were by
now less clearly pronounced, more patients (75.8%) in
the A + HA group assessed the treatment outcome as
positive than in group A (63.6%) (Fig. 1). Similar
numbers of patients in the two groups had no restricted
ability to walk 100 m at 2 years (A 78.8%, A + HA







































pre 6 hours 2 weeks 3 months 1 year 2 years
Fig. 4 Pain on walking
100 m. The light bars
represent pain-free patients,
the dark bars patients with
pain. (A group arthroscopy;






































pre 6 hours 2 weeks 3 months 1 year 2 years pre 6 hours 2 weeks 3 months 1 year 2 years
A group A+HA groupFig. 5 Night pain. The light
bars represent pain-free
patients, the dark bars
patients with pain. (A group
arthroscopy; A + HA group
arthroscopy + hyaluronic
acid)




























pre 6 h  2 w 3 mo 1 y 2 y
Fig. 3 Restricted ability to
walk 100 m (A group
arthroscopy; A + HA group
arthroscopy + hyaluronic
acid)
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patients compared with the baseline visit, was clearly
greater in the A + HA group (improvement of one or
more score points in 75.8% of patients) than in group
A (56.3%). At 2 years almost a third of the patients in
both groups suffered from pain on walking 100 m (A
33.3%, A + HA 27.3%) (Fig. 4). Pain at rest affected
only 12.1% of patients in the group treated with HA
compared to twice as many patients (24.2%) from
group A (Fig. 5). The Mann–Whitney statistics showed
a descriptive superiority for the A + HA group for the
global assessment by patients, pain on walking 100 m
and pain at rest, while non-inferiority was shown for
the A + HA group for restricted ability to walk 100 m.
There were no signs of any undesirable effects due to
Viscoseal.
In summary, it can be stated that there was no dif-
ference between the two treatment methods in their
short-term effect. However, the temporary replace-
ment of synovial fluid with Viscoseal after arthros-
copy conferred additional benefits for a considerable
proportion of the patients treated in this way. Findings
at 1 year for all efficacy parameters were more
favourable in this group of patients and the Mann–
Whitney statistics consistently demonstrated the supe-
riority of this treatment regime. Findings from the
patient follow-up at 2 years also showed that Visco-
seal still had a stabilising effect on the beneficial ef-
fects of lavage and debridement. No adverse events or
effects of the supplementary treatment with HA were
found in any patient and therefore the benefit-risk
assessment of synovial fluid substitution with Visco-
seal was positive overall.
Discussion
The treatment of osteoarthritic changes with arthro-
scopic joint lavage, possibly supplemented by cartilage
smoothing, may be used when conservative measures
are no longer sufficiently effective. The underlying
assumption is that the deposition of small particles of
worn cartilage in the synovial membrane causes a non-
bacterial form of synovitis and an associated increase
in effusion leading to continuing pain and irritation of
the joint (‘‘activated osteoarthritis’’). Irrigation not
only removes the particles of worn cartilage (detritus)
but also the enzymes that destroy cartilage. Additional
debridement removes fragments of cartilage that are
loosened but still attached, from which further detritus
could arise. The surgically removed fragments must
also be thoroughly washed out of the joint.
Literature reports at 2 years show that 25–93%
(average 61.0%) of patients undergoing joint lavage
alone and between 0 and 94% (average 62.5%) of
those also undergoing debridement had improvements
in their symptoms [8]. Later publications by Muckley
[16] and Hempfling [9] compared the carry-over effects
of knee joint lavage with those of joint lavage +
debridement over a period of 4 years after the proce-
dure. It was found that the debridement group bene-
fited more in the three-year period after the procedure
than those in whom only joint lavage was carried out.
Four years after the procedure, patients assessed the
two procedures as almost equally effective. In view of
the favourable course during the first 3 years, sparing
debridement is therefore preferable to joint lavage
alone. In their studies Muckley and Hempfling also
investigated the effect of the severity of chondral
lesions, assessed according to Ficat and Hungerford, on
the postoperative outcome. They found that the
greater the severity of chondral damage, the less good
the outcomes were in the period up to 4 years after the
procedure. Patients with low-grade damage showed a
considerably more pronounced improvement which
persisted for a longer period. If progress (using the
CGI parameter) at 2 years from the studies mentioned
above is compared with the present study, it is again
clear that patients treated with HA derive additional
benefit: this applies both for the assessment according
to treatment (i.e. lavage alone versus lavage +
debridement) and also according to the severity of
arthroscopically classified chondral lesions (Figs. 6, 7).
In contrast with the above findings, a prospective
controlled study by Moseley et al. [15] in patients with
osteoarthritis of the knee found no appreciable dif-














































Fig. 6 Overall assessment by patients after joint lavage or joint
lavage plus debridement. Patients with the assessment ‘‘very
good’’ and ‘‘good’’ for the CGI were taken together as patients
with a good overall result. The patient groups treated with
hyaluronic acid are marked with HA
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debridement and a placebo operation. In this study,
severity was radiologically classified according to
Kellgren [12]. Precise arthroscopic classification of the
intra-articular status (e.g. according to Outerbridge or
Ficat and Hungerford) was not carried out—particu-
larly in the placebo group which received only a skin
incision. Torn meniscus was resected not only in the
debridement group but also in some cases in the lavage
group. Radiological classification of chondral lesions is
not comparable with arthroscopic classification, since
some lesions that can be detected by arthroscopy
cannot be visualised radiologically. Moseley et al. [15]
evidently detected only those chondral lesions that had
already resulted in radiologically detectable secondary
damage. Comparison of the results described here with
those of Moseley et al. is therefore not possible.
The positive result of both joint lavage alone and of
joint lavage combined with debridement is a joint free
from detritus. However, during joint lavage the syno-
vial fluid is also completely washed out of the joint. In
experimental studies, irrigating fluids have been shown
to have a negative effect on cartilage metabolism.
Bulstra et al. [3] carried out in-vitro investigations on
the rate of proteoglycan synthesis under the influence
of various irrigating fluids on complete rat patella ex-
plants. The preparations were incubated for 1 h in each
solution and the rate of proteoglycan synthesis deter-
mined for a period of 16 h based on 35SO4 incorpora-
tion into the cartilage. All irrigation fluids inhibited the
rate of proteoglycan synthesis. Negative deviation from
the control was 5% for Ringer’s solution, 10% for
Ringer’s glucose, 20% for physiological saline and
Ringer’s lactate and 55% for Betadine. In another
study, Reagan et al. [18] placed sections of cartilage
in various commercially obtainable irrigation fluids.
35SO4 incorporation showed that physiological saline
and phosphate buffer, compared with normal nutrient
media, had a negative effect on cartilage metabolism.
Similar findings were also obtained by Straehley et al.
[20].
Several studies have been carried out to investigate
the effects of using HA-containing solutions as a
synovial fluid replacement following arthroscopy and
also to remove potentially harmful irrigating solutions
from the joint. The first investigations were performed
1995 by Edelson et al. [4] in 26 patients (33 knees) with
symptoms refractory to treatment due to radiologically
confirmed degenerative disease of the knee joint. All
knees underwent joint lavage and 16 were then given
an intra-articular injection of 3 ml HA solution
(molecular weight of HA: 0.5–1 million Da). All pa-
tients experienced an improvement in their symptoms
(pain and function) which was maintained for up to
2 years. There was no significant difference between
the two methods of treatment. Unfortunately, the re-
port gives no indication of adequate biostatic study
planning or of the characteristics and amount of the
HA administered, which reduces the significance of the
study. In a randomised study in patients with osteoar-
thritis of the knee, Foster and Straw [7] compared the
effect of arthroscopic irrigation with a series of five
intra-articular (i.a.) injections of extractive HA. After
aspiration of the synovial fluid, 19 patients received i.a.
HA injections, while 17 patients underwent joint la-
vage with physiological saline, sometimes combined
with debridement. At baseline, the Knee Society
Function Score in patients in the arthroscopy group
showed significantly worse values. At the end of the
study, inter-group comparison for all parameters
investigated showed the superiority of HA. However,
the extent of the improvement was not reported.
Moreover, 12 patients dropped out during this one-
year study of which 10 were from the HA group. Five
of these HA patients required arthroscopic treatment
and three were referred for knee replacement. It is
therefore possible that at the end of the study the HA
group consisted only of those nine patients who re-
mained in the study because of satisfactory treatment
outcomes. In this case the statistical conclusion must be
considered with great caution.
The benefit of the combined use of joint irrigation
and i.a. HA was analysed by Vad et al. [21] in a study
of 81 patients with osteoarthritis of the knee. All
patients were treated with three i.a. injections of cross-
linked extractive HA at weekly intervals. In 44
patients, joint lavage was performed using the closed
needle method 1 week before starting the series of
injections. Patients who obtained pain reduction of at
least 50% and those who assessed treatment outcome
















































Fig. 7 Overall assessment by patients after joint lavage or joint
lavage plus debridement related to the severity of chondral
damage before treatment
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cessfully treated. According to this criterion, the suc-
cess rate for i.a. HA alone was 54 %, at 1.1 years after
treatment while it was 79.5% for the combined treat-
ment comprising lavage and HA. Moreover, eight pa-
tients reacted to the treatment with local reddening
and pain, which resolved spontaneously in only six
patients. Mathies [14] investigated the effects of tem-
porary replacement of synovial fluid with a 0.5% HA
solution (Viscoseal) after arthroscopic meniscecto-
my. A suction drain was installed for postoperative
patient care in all the 50 patients included in the study.
In 25 patients the HA solution was instilled into the
joint through the suction drain which was then blocked
and the knee manipulated. The drain was reopened 20–
30 min later on the assumption that sufficient HA
would by then have been deposited on the joint sur-
faces. Pain at rest and on exercise was considerably less
in patients in the HA group during the first few days
after the procedure. In fact, at the final examination on
day 28, patients in the HA group showed a much more
pronounced reduction in joint swelling. They also took
less diclofenac during the study, had better Lysholm
scores and assessed the outcome of the procedure more
favourably overall. In the Investigator’s view, the
benefit of Viscoseal administration was that patients
could be mobilised earlier because of reduced pain.
The further postoperative progress of the patients in
this study is not reported.
The acute effects of exogenous HA in the joint (for
example, improved lubrication) are evident and the
subject of many publications. The mechanisms under-
lying the carry-over-effect are not yet well understood.
Bulstra [3] in a rabbit model of chronic osteoarthritis,
showed that intra-articular HA following joint lavage
was able to enhance the chondrocyte metabolism and
reduce the rate of chondrocyte apoptosis. Smith and
Ghosh [19] in cultures of ‘‘arthritic’’ human synovio-
cytes, showed that exogenous HA stimulated the syn-
thesis of endogenous HA. Only recently, in patients
who fulfilled the criteria for knee replacement, Mathies
et al. [13] reported a long lasting improvement of the
viscous and elastic moduli of their synovial fluid after
five intra-articular injections of HA, which was paral-
leled by a clinical improvement such that most patients
did not require arthroplasty during the 12 months after
treatment.
In our current study, the short-term benefit of post-
arthroscopic substitution of synovial fluid with HA
described by Mathies et al. [14] was not demonstrated.
It may be that the more severe pain symptoms due to
the placing of the suction drain played a role. In our
two-year study, however, the positive long-term effects
of this new treatment option were robustly demon-
strated over all efficacy parameters. The stabilising
effect of Viscoseal on the clinical improvement
achieved by lavage and debridement was still evident
even 2 years after treatment.
The positive result of the present study is further
supported by direct comparison with the findings of
Hempfling [9] (Fig. 6). If the assessment by patients in
the HA group of this study is compared with that of the
group of patients not treated with HA from the current
and previous studies, the additional benefit of the HA
treatment becomes very evident. It is interesting that
the findings for patients treated with HA in the
debridement group are better than those for irrigation
alone. The effect of the severity of chondral damage
was also taken into account, patients receiving irriga-
tion alone and irrigation + debridement being taken
together for a more easy understanding (Fig. 7).
Though the groups of patients being considered may be
different, and a direct comparison of the data from
previous studies with those from the present study
must be interpreted with caution, it seems that HA
treatment led to better results over 2 years for all levels
of severity.
In summary, it may be said that the use of Visco-
seal after arthroscopy is beneficial both for patients in
the lavage group and for those who also underwent
debridement. The improvement achieved in function
and pain is clearly greater and persists over a period of
2 years. It is interesting to note that particular patients
with advanced chondral damage benefit from the use
of HA as they still assess the outcome of treatment as
being positive 2 years after the procedure. Our study
findings document the benefits of treating osteoarthri-
tis of the knee by joint lavage and by joint lavage
combined with sparing debridement. If these measures
are supplemented at the end of the surgical procedure
by intra-articular instillation of HA, even more
favourable and longer lasting treatment benefits can be
expected, with a clear improvement in the quality of
life and mobility of these patients.
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